Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
FREMONT, Calif., November 10, 2025–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today…
Browsing Tag